Ellagic acid reduces methotrexate-induced apoptosis and mitochondrial dysfunction via up-regulating Nrf2 expression and inhibiting the IĸBα/NFĸB in rats

Daru. 2019 Dec;27(2):721-733. doi: 10.1007/s40199-019-00309-9. Epub 2019 Nov 18.

Abstract

Background: The clinical application of methotrexate (MTX), an efficacious cytotoxic drug, is restricted due to its associated liver toxicity. Ellagic acid (EA), a natural polyphenol, possesses hepatoprotective, antioxidant and anti-inflammatory properties.

Objectives: The present study seeks to address the hepatoprotective effects of Ellagic acid (EA) against MTX-mediated oxidative stress (OS) and widen our current knowledge of the underlying molecular mechanisms of MTX toxicity.

Methods: Wistar rats were orally given EA (5 mg/kg and 10 mg/kg) for 10 successive days and at the end of the third day they were administered a single dose of MTX (20 mg/kg i.p).

Results: After performing biochemical analysis, liver enzymes and malondialdehyde were significantly higher in the MTX group, indicating hepatic oxidative damage. MTX-induced OS was further confirmed with observation of events such as reactive oxygen species (ROS) overproduction, mitochondrial outer membrane potential decrease, mitochondrial swelling, cytochrome c release and caspase-3/9 increase, resulting in apoptosis. Furthermore, overexpression of pro-inflammatory factors such as nuclear factor kappa B (NF-ĸB) and interleukin 6 (IL-6) indicated the MTX-induced inflammation in MTX-treated group. Interestingly, EA was able to significantly prevent OS, mitochondrial dysfunction, apoptosis and inflammation induced by MTX. Also, EA-treated rats demonstrated significant upregulation of both nuclear factor erythroid 2-related factor 2 (Nrf2) and hemoxygenase-1 (HO-1), which were considerably downregulated in MTX-treated rats.

Conclusions: EA protects rats against MTX-induced apoptosis and mitochondrial dysfunction via up-Regulating Nrf2 and HO-1 expression and inhibiting the NF-κB signaling pathway. Therefore, EA may protect patients against MTX-induced hepatotoxicity and encourage its clinical application. Graphical abstract Beneficial effect of Ellagic acid (EA) on Methotrexate (MTX)-induced liver injury: molecular mechanism.

Keywords: Apoptosis; Ellagic acid; Inflammation; Mitochondrial dysfunction; Oxidative stress.

MeSH terms

  • Administration, Oral
  • Animals
  • Apoptosis / drug effects
  • Ellagic Acid / administration & dosage*
  • Ellagic Acid / pharmacology
  • Gene Expression Regulation / drug effects
  • Humans
  • Male
  • Malondialdehyde / metabolism
  • Methotrexate / adverse effects*
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • NF-E2-Related Factor 2 / metabolism*
  • NF-KappaB Inhibitor alpha / metabolism*
  • NF-kappa B / metabolism*
  • Rats
  • Rats, Wistar
  • Up-Regulation

Substances

  • NF-E2-Related Factor 2
  • NF-kappa B
  • Nfe2l2 protein, rat
  • NF-KappaB Inhibitor alpha
  • Ellagic Acid
  • Malondialdehyde
  • Methotrexate